ASTRAZENECA
Updates & Highlights
AstraZeneca CEO Pascal Soriot goes one-on-one with Jim Cramer
AstraZeneca CEO Pascal Soriot goes one-on-one with Jim Cramer
CNBC · about 4 hours ago
AstraZeneca CEO says AI is reshaping drug development — and helping boost the odds of success
AstraZeneca CEO says AI is reshaping drug development — and helping boost the odds of success
CNBC · about 5 hours ago
AstraZeneca CEO on firm's transfer to NYSE
AstraZeneca CEO on firm's transfer to NYSE
qz.com · about 8 hours ago
Recent Openings
View all 9 jobsPrincipal AI Engineer - Evinova
Barcelona, CT, ES
Senior AI Engineer
Cambridge, ENG, GB
Associate Principal AI & ML Engineer – Evinova
London, ENG, GB
Associate Principal AI Research Scientist (Fundamental AI Research for Digital Biology)
Boston, MA, US
All Jobs
Principal AI Engineer - Evinova
Barcelona, CT, ES
Senior AI Engineer
Cambridge, ENG, GB
Associate Principal AI & ML Engineer – Evinova
London, ENG, GB
Associate Principal AI Research Scientist (Fundamental AI Research for Digital Biology)
Boston, MA, US
Principal AI& ML Engineer – Evinova
London, ENG, GB
Associate Principal AI& ML Engineer – Evinova
London, ENG, GB
Associate Principal AI Research Scientist (Fundamental AI Research for Digital Biology)
Wilmington, DE, US
Data & AI Engineer Intern
Barcelona, CT, ES
Principal AI Engineer - Evinova
Barcelona, CT, ES
Culture & Mission
Benefits & Perks
Equity/Stock Options
Ownership in the company
Health Insurance
Medical, dental & vision
Remote Work
Work from anywhere flexibility
Learning Budget
Professional development
Generous PTO
Paid time off
Parental Leave
Family-friendly policies
401(k) Match
Retirement savings
Tech Stack
Core Values
Innovation
Pushing boundaries in AI/ML technology
Collaboration
Working together to achieve more
Excellence
Striving for the highest quality
Impact
Making a difference in the world
Office Locations
Team
Are you on the team at AstraZeneca?
Claim this company page to verify ownership, edit details, and respond to applicants.
Claim this company →News & Press
20 recentAstraZeneca CEO: AI helps us make smarter choices when developing drugs
AstraZeneca CEO: AI helps us make smarter choices when developing drugs
CNBC · about 4 hours ago
AstraZeneca CEO Pascal Soriot goes one-on-one with Jim Cramer
AstraZeneca CEO Pascal Soriot goes one-on-one with Jim Cramer
CNBC · about 4 hours ago
AstraZeneca CEO says AI is reshaping drug development — and helping boost the odds of success
AstraZeneca CEO says AI is reshaping drug development — and helping boost the odds of success
CNBC · about 5 hours ago
AstraZeneca CEO on firm's transfer to NYSE
AstraZeneca CEO on firm's transfer to NYSE
qz.com · about 8 hours ago
Analyst Reaffirms Buy on AstraZeneca, Citing Underappreciated Non‑Oncology Growth and Blockbuster Pipeline Upside
Analyst Reaffirms Buy on AstraZeneca, Citing Underappreciated Non‑Oncology Growth and Blockbuster Pipeline Upside
TipRanks · about 9 hours ago
NYSE Content Update: AstraZeneca Celebrates Largest Transfer in NYSE History
NYSE Content Update: AstraZeneca Celebrates Largest Transfer in NYSE History
Investing News Network · about 12 hours ago
NYSE Content Update: AstraZeneca Celebrates Largest Transfer in NYSE History
NYSE Content Update: AstraZeneca Celebrates Largest Transfer in NYSE History
Yahoo Finance · about 14 hours ago
AstraZeneca adds FDA cell and gene veteran—Chutes & Ladders
AstraZeneca adds FDA cell and gene veteran—Chutes & Ladders
Fierce Biotech · about 15 hours ago
Watch AstraZeneca Broadens US Growth Push
Watch AstraZeneca Broadens US Growth Push
Bloomberg.com · 1 day ago
AUDIO: AstraZeneca pulls critical breast cancer drug from shelves
AUDIO: AstraZeneca pulls critical breast cancer drug from shelves
Australian Broadcasting Corporation · 2 days ago
AstraZeneca CEO: AI is affecting every part of our company
AstraZeneca CEO: AI is affecting every part of our company
CNBC · 2 days ago
AstraZeneca Sees Encouraging Survival Trend In Liver Cancer Trial
AstraZeneca Sees Encouraging Survival Trend In Liver Cancer Trial
Yahoo · 2 days ago
Can AstraZeneca's Expanding Cancer Portfolio Sustain Momentum?
Can AstraZeneca's Expanding Cancer Portfolio Sustain Momentum?
Yahoo Finance · 3 days ago
Leading Bank maintains sell on AstraZeneca at 11,500p as ASCO glow fails to resolve key pipeline questions
Leading Bank maintains sell on AstraZeneca at 11,500p as ASCO glow fails to resolve key pipeline questions
Proactive financial news · 3 days ago
Leading Bank maintains sell on AstraZeneca at 11,500p as ASCO glow fails to resolve key pipeline questions
Leading Bank maintains sell on AstraZeneca at 11,500p as ASCO glow fails to resolve key pipeline questions
Yahoo! Finance Canada · 3 days ago
James Wu: Some Amazing Life Advice at the ASCO26 AstraZeneca Lungsphere Leadership Exchange
James Wu: Some Amazing Life Advice at the ASCO26 AstraZeneca Lungsphere Leadership Exchange
Oncodaily · 3 days ago
ASCO26: AstraZeneca unveils data it hopes will persuade FDA to approve oral SERD
ASCO26: AstraZeneca unveils data it hopes will persuade FDA to approve oral SERD
FirstWord Pharma · 3 days ago
SUNFLOWER Lupus Trial Puts AstraZeneca and ICON in Focus for Long‑Term Investors
SUNFLOWER Lupus Trial Puts AstraZeneca and ICON in Focus for Long‑Term Investors
TipRanks · 3 days ago
AstraZeneca’s (AZN) CARES Phase III Clinical Programme Fails to Meet Primary End Point
AstraZeneca’s (AZN) CARES Phase III Clinical Programme Fails to Meet Primary End Point
Yahoo Finance · 4 days ago
AstraZeneca reports ‘further positive results’ from Phase 3 SERENA-6 trial
AstraZeneca reports ‘further positive results’ from Phase 3 SERENA-6 trial
TipRanks · 4 days ago